Could The Cyclopharm Limited (ASX:CYC) Ownership Structure Tell Us Something Useful?




  • In Business
  • 2019-11-09 00:19:00Z
  • By Simply Wall St.
Could The Cyclopharm Limited (ASX:CYC) Ownership Structure Tell Us Something Useful?
Could The Cyclopharm Limited (ASX:CYC) Ownership Structure Tell Us Something Useful?  

The big shareholder groups in Cyclopharm Limited (ASX:CYC) have power over the company. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ownership over time. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, 'Don't tell me what you think, tell me what you have in your portfolio.

With a market capitalization of AU$83m, Cyclopharm is a small cap stock, so it might not be well known by many institutional investors. Taking a look at our data on the ownership groups (below), it's seems that institutions own shares in the company. Let's take a closer look to see what the different types of shareholder can tell us about CYC.

Check out our latest analysis for Cyclopharm

What Does The Institutional Ownership Tell Us About Cyclopharm?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

As you can see, institutional investors own 31% of Cyclopharm. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Cyclopharm's historic earnings and revenue, below, but keep in mind there's always more to the story.

We note that hedge funds don't have a meaningful investment in Cyclopharm. While there is some analyst coverage, the company is probably not widely covered. So it could gain more attention, down the track.

Insider Ownership Of Cyclopharm

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

Our most recent data indicates that insiders own a reasonable proportion of Cyclopharm Limited. Insiders own AU$9.2m worth of shares in the AU$83m company. I would say this shows alignment with shareholders, but it is worth noting that the company is still quite small; some insiders may have founded the business. You can click here to see if those insiders have been buying or selling.

General Public Ownership

The general public holds a 14% stake in CYC. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

Private Equity Ownership

Private equity firms hold a 10% stake in CYC. This suggests they can be influential in key policy decisions. Sometimes we see private equity stick around for the long term, but generally speaking they have a shorter investment horizon and -- as the name suggests -- don't invest in public companies much. After some time they may look to sell and redeploy capital elsewhere.

Private Company Ownership

Our data indicates that Private Companies hold 34%, of the company's shares. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Cyclopharm better, we need to consider many other factors.

I like to dive deeper into how a company has performed in the past. You can access this interactive graph of past earnings, revenue and cash flow, for free.

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

COMMENTS

More Related News

How Much Of IPH Limited (ASX:IPH) Do Institutions Own?
How Much Of IPH Limited (ASX:IPH) Do Institutions Own?

The big shareholder groups in IPH Limited (ASX:IPH) have power over the company. Large companies usually have...

What Kind Of Investor Owns Most Of CSX Corporation (NASDAQ:CSX)?
What Kind Of Investor Owns Most Of CSX Corporation (NASDAQ:CSX)?

The big shareholder groups in CSX Corporation (NASDAQ:CSX) have power over the company. Institutions often own shares...

How Many SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Shares Do Institutions Own?
How Many SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Shares Do Institutions Own?

A look at the shareholders of SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) can tell us which group is most powerful...

How Much Of SCYNEXIS, Inc. (NASDAQ:SCYX) Do Institutions Own?
How Much Of SCYNEXIS, Inc. (NASDAQ:SCYX) Do Institutions Own?

A look at the shareholders of SCYNEXIS, Inc. (NASDAQ:SCYX) can tell us which group is most powerful. Large companies...

Could PLx Pharma Inc.
Could PLx Pharma Inc.'s (NASDAQ:PLXP) Investor Composition Influence The Stock Price?

If you want to know who really controls PLx Pharma Inc. (NASDAQ:PLXP), then you'll have to look at the makeup of its...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business